Peter Fail, MD
Advanced Heart Failure and Transplant Cardiology · Houma, LANPI 1437156429
Payments from drug & device makers
Across 952 payments — averaging $1153.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$434K
- Abbott$227K
- Atricure, Inc.$163K
- Novartis$97K
- Merck$73K
- Edwards Lifesciences$36K
- plus $68K from 33 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
Too few advanced heart failure and transplant cardiology providers in Louisianato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other advanced heart failure and transplant cardiology in Houma
- Shane PrejeanHouma$102K
- David MollBaton Rouge$927K
- Siby AyallooreOpelousas$919K
- Selim KrimNew Orleans$594K
- Clement EiswirthNew Orleans$441K
- Frank SmartNew Orleans$196K
- Sapna DesaiNew Orleans$150K
- Hector VenturaNew Orleans$63K
- Senthil AnandNew Orleans$51K
- Phillip SmithBaton Rouge$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.